betamethasone dipropionate
- RxCUI
- 19254
- RxNorm name
- betamethasone dipropionate
- Term type
- PIN
- Status
- Active
- Updated
- 2026-10-27 19:32:40
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042005
- Active start
- 042005
- Multiple ingredient
- NO
- Branded
- NO
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| betamethasone | 1514 |
Source Vocabulary Codes#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Cosette Pharmaceuticals, Inc. | 4cc3b34f-9120-3362-0932-42d7024c8f89 | 2023-11-22 | Adverse reactions | BETAMETHASONE DIPROPIONATE |
| Betamethasone dipropionate | BETAMETHASONE DIPROPIONATE | A-S Medication Solutions | 1c15cbe5-51d6-4a1a-bb42-811f1d84ae66 | 2023-10-31 | Adverse reactions | BETAMETHASONE DIPROPIONATE |
| betamethasone dipropionate | BETAMETHASONE DIPROPIONATE | Viona Pharmaceuticals Inc | 9adfb030-17c3-46eb-bf85-a90cabafd367 | 2023-08-07 | Adverse reactions | BETAMETHASONE DIPROPIONATE |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | A-S Medication Solutions | fe946b6d-2b6d-490b-8d63-c865e1c43321 | 2023-07-31 | Adverse reactions | BETAMETHASONE DIPROPIONATE |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | A-S Medication Solutions | 0aaa5de4-442b-4184-8378-ea47831e9663 | 2023-07-06 | Adverse reactions | BETAMETHASONE DIPROPIONATE |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Padagis Israel Pharmaceuticals Ltd | 7bd2646c-f34a-4824-8f66-c41e77db19d2 | 2023-03-31 | Warnings, Adverse reactions | BETAMETHASONE DIPROPIONATE |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | A-S Medication Solutions | 7da1c732-3477-4031-b776-149bd5ceea27 | 2023-03-06 | Adverse reactions | BETAMETHASONE DIPROPIONATE |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Actavis Pharma, Inc. | aa3f4012-7597-422d-8bcc-00102780a152 | 2023-02-28 | Adverse reactions | BETAMETHASONE DIPROPIONATE |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Cosette Pharmaceuticals, Inc. | c9839c0a-bee5-0ef7-8933-e6231c440407 | 2022-11-15 | Adverse reactions | BETAMETHASONE DIPROPIONATE |
| betamethasone dipropionate | BETAMETHASONE DIPROPIONATE | Zydus Lifesciences Limited | f531da27-2435-49a3-8992-c65240c6a7fe | 2022-11-05 | BETAMETHASONE DIPROPIONATE | |
| Betamethasone dipropionate | BETAMETHASONE DIPROPIONATE | Zydus Pharmaceuticals USA Inc. | 18d80661-72ad-4a83-917f-a80ce37a5568 | 2022-10-05 | Adverse reactions | BETAMETHASONE DIPROPIONATE |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Proficient Rx LP | f1be7c91-5408-4d31-8673-b691089aadce | 2022-04-01 | Warnings, Adverse reactions | BETAMETHASONE DIPROPIONATE |
| Betamethasone Dipropionate | BETAMETHASONE DIPROPIONATE | Padagis Israel Pharmaceuticals Ltd | e6018480-7788-472d-a2d1-ccccffcd258e | 2022-02-28 | Adverse reactions | BETAMETHASONE DIPROPIONATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | C05AA | Corticosteroids | ATC1-4 | betamethasone | |
| ATC | S03BA | Corticosteroids | ATC1-4 | betamethasone | |
| ATC | S02BA | Corticosteroids | ATC1-4 | betamethasone | |
| ATC | R01AD | Corticosteroids | ATC1-4 | betamethasone | |
| ATC | A07EA | Corticosteroids acting locally | ATC1-4 | betamethasone | |
| ATC | S01BA | Corticosteroids, plain | ATC1-4 | betamethasone | |
| ATC | D07AC | Corticosteroids, potent (group III) | ATC1-4 | betamethasone | |
| ATC | D07XC | Corticosteroids, potent, other combinations | ATC1-4 | betamethasone | |
| ATC | S01CB | Corticosteroids/antiinfectives/mydriatics in combination | ATC1-4 | betamethasone | |
| ATC | R03BA | Glucocorticoids | ATC1-4 | betamethasone | |
| ATC | H02AB | Glucocorticoids | ATC1-4 | betamethasone | |
| FDASPL | N0000175576 | Corticosteroid | EPC | has_epc | betamethasone |
| FDASPL | N0000175450 | Corticosteroid Hormone Receptor Agonists | MOA | has_moa | betamethasone |
| MEDRT | D001623 | Betamethasone | CHEM | has_ingredient | betamethasone dipropionate |
| MEDRT | D001623 | Betamethasone | CHEM | has_ingredient | betamethasone |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | betamethasone dipropionate |
| MEDRT | D003876 | Dermatitis, Atopic | DISEASE | may_treat | betamethasone |
| MEDRT | D012628 | Dermatitis, Seborrheic | DISEASE | may_treat | betamethasone dipropionate |
| MEDRT | D012628 | Dermatitis, Seborrheic | DISEASE | may_treat | betamethasone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | betamethasone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | betamethasone dipropionate |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | betamethasone dipropionate |
| MEDRT | D005533 | Foot Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D005533 | Foot Dermatoses | DISEASE | may_treat | betamethasone dipropionate |
| MEDRT | D006229 | Hand Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D006229 | Hand Dermatoses | DISEASE | may_treat | betamethasone dipropionate |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | betamethasone dipropionate |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | betamethasone |
| MEDRT | D007868 | Leg Dermatoses | DISEASE | may_treat | betamethasone dipropionate |
| MEDRT | D007868 | Leg Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D009181 | Mycoses | DISEASE | ci_with | betamethasone dipropionate |
| MEDRT | D009181 | Mycoses | DISEASE | ci_with | betamethasone |
| MEDRT | D011538 | Pruritus Ani | DISEASE | may_treat | betamethasone dipropionate |
| MEDRT | D011538 | Pruritus Ani | DISEASE | may_treat | betamethasone |
| MEDRT | D011565 | Psoriasis | DISEASE | may_treat | betamethasone dipropionate |
| MEDRT | D011565 | Psoriasis | DISEASE | may_treat | betamethasone |
| MEDRT | D016553 | Purpura, Thrombocytopenic, Idiopathic | DISEASE | ci_with | betamethasone dipropionate |
| MEDRT | D016553 | Purpura, Thrombocytopenic, Idiopathic | DISEASE | ci_with | betamethasone |
| MEDRT | D012536 | Scalp Dermatoses | DISEASE | may_treat | betamethasone |
| MEDRT | D012536 | Scalp Dermatoses | DISEASE | may_treat | betamethasone dipropionate |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | betamethasone dipropionate |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | betamethasone |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | betamethasone dipropionate |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | betamethasone |
| MEDRT | N0000008297 | Antipruritic Activity | PE | has_pe | betamethasone dipropionate |
| MEDRT | N0000008297 | Antipruritic Activity | PE | has_pe | betamethasone |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | betamethasone dipropionate |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | betamethasone |
| MEDRT | N0000009928 | Decreased Cellular Migration | PE | has_pe | betamethasone dipropionate |
| MEDRT | N0000009928 | Decreased Cellular Migration | PE | has_pe | betamethasone |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | betamethasone |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | betamethasone dipropionate |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | betamethasone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | betamethasone dipropionate |
| MEDRT | N0000008700 | Decreased Lysosomal Function | PE | has_pe | betamethasone |
| MEDRT | N0000008700 | Decreased Lysosomal Function | PE | has_pe | betamethasone dipropionate |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | betamethasone |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | betamethasone dipropionate |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | betamethasone |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | betamethasone dipropionate |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | betamethasone |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | betamethasone dipropionate |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | betamethasone dipropionate |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | betamethasone |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| CODES | SNOMEDCT | 88736007 |
| CODES | USP | m8960 |
| CODES | VUID | 4018642 |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | United States Pharmacopeia |
| SOURCES | Source | US Edition of SNOMED_CT |
| SOURCES | Source | Veterans Health Administration National Drug File |